Palliative chemotherapy followed by consolidation radiotherapy in patients with advanced and metastatic non-small cell lung cancer not suitable for radical treatment

No abstract is available for this paper.

• Publication year

  2012

• Venue

  The Chinese-German Journal of Clinical Oncology

• Publication date

  2012-06-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.2298/AOO1202008E
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Implications of Delayed Initiation of Radiotherapy: Accelerated Repopulation after Induction Chemotherapy for Stage III Non-small Cell Lung Cancer

  2011cited by this paper
• Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline

  2011cited by this paper
• Customizing systemic therapy in patients with advanced non-small cell lung cancer

  2011cited by this paper
• Experience of first- and subsequent-line systemic therapy in the treatment of non-small cell lung cancer

  2011cited by this paper
• Palliative thoracic radiotherapy for lung cancer: a systematic review.

  2008cited by this paper
• A review of hypofractionated palliative radiotherapy

  2007cited by this paper
• Scottish Intercollegiate Guidelines Network (SIGN) 84 -- National Clinical Guideline for the Management of Breast Cancer in Women.

  2007cited by this paper
• A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer

  2006cited by this paper
• Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer.

  2005cited by this paper
• Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study.

  2005cited by this paper
• Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.

  2004cited by this paper
• High incidence of brain metastases at the time of death in women with metastatic breast cancer treated with trastuzumab

  2004cited by this paper
• Hypofractionated radiotherapy for advanced non-small-cell lung cancer: is the LINAC half full?

  2004cited by this paper
• Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

  2004cited by this paper
• Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer.

  2003cited by this paper
• Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

  2002cited by this paper
• Treatment of advanced non-small cell lung cancer

  2002cited by this paper
• A short radiotherapy course for locally advanced non-small cell lung cancer (NSCLC): effective palliation and patients' convenience.

  2002cited by this paper
• Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial

  2002cited by this paper
• Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15).

  2002cited by this paper
• Palliative radiotherapy regimens for non-small cell lung cancer.

  2001cited by this paper
• Palliative treatment of advanced non small cell lung cancer with weekly fraction radiotherapy.

  2000cited by this paper
• Short-course palliative radiotherapy in non-small-cell lung cancer: results of a prospective study.

  2000cited by this paper
• Hypofractionated Radiation Therapy for Inoperable Advanced Stage Non-small Cell Lung Cancer

  1999cited by this paper
• Inoperable non-small cell lung cancer: palliative radiotherapy with two weekly fractions.

  1998cited by this paper
• Palliative radiotherapy for lung cancer: two versus five fractions.

  1997cited by this paper
• Randomized trial of two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status.

  1996cited by this paper
• Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.

  1996cited by this paper
• Palliative radiation for stage 3 non-small cell lung cancer--a prospective study of two moderately high dose regimens.

  1995cited by this paper
• Hypofractionated irradiation for inoperable non-small cell lung cancer.

  1995cited by this paper
• A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.

  1992cited by this paper
• A randomized study on palliative radiation therapy for inoperable non small cell carcinoma of the lung.

  1988cited by this paper
• Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial.

  1985cited by this paper

• Paclitaxel targeting to lungs by way of liposomes prepared by the effervescent dispersion technique

  2013cites this paper